References to Primary Literature
- HARRISON T, WILLIAMS BJ, SWAIN CJ, BALL RG: PiperidIncether based hNICI antagonists 1: determination of the relative and absolute sterochemical requirements. Btootg. Med. Chem. Lett (1994) 4(21):2545–2550.
- LADDUWAHETTY T, KEOWN L, CASCIERI MA, SADOWSKIS: Morpholine-based substance P antagonists: assess-ment of the 3-point binding modeL Bioorg. Med. Chem. Lett. (1994) 4(16)19174920.
- SEWARD EM, SWAIN CJ, MERCHANT KJ, OWEN SN, SABIN V, CASCIERI MA, SADOWSKI S, STRADER C, BAKER R: Quinuclidine-based NICi antagonists 1. 3-Benzyloxy- 1-azabicyclof2.2.2.]octanes. Btoorg. Med. Chem. Lett. (1993) 3(6):1361–1366.
- SWAIN CJ, SEWARD EM, SABIN V, OWEN S, CASCIERI MA, SADOWSKI S, STRADER C, BAKER R, BALL RG: Quinuclidine-based NICI antagonists 2. Determination of the ab-solute stereochemical requirements. Bloom. Med. Chem. Lett. (1993) 3(8):1703–1706.
- STEVENSON GI, MACLEOD AM, HUSCROFT I, CASCIERI MA, SADOWSKI S, BAKER R: 4,4-Disubstituted piperidines: a new class of NICi antagonists. J. Med. Chem. (1995) 38:1264–1266.
- MACLEOD AM, MERCHANT KJ, BROOKFIELD F, KELLEHER F, STEVENSON GI, OWENS AP, SWAIN CJ, CASCIERI MA, SADOWSKI S, BER E, STRADER CD, MACINTYRE DE, METZGER JM, BALL RG, BAKER R: Identification of L-tryp-tophan derivatives with potent and selective antagonist activity at the NICI. receptor. J. Med. Chem. (1994) 37:1269–1274.
- LEWIS RT, MACLEOD AM, MERCHANT KJ, KELLEHER F,SANDERSON I, HERBERT RH, CASCIERI MA, SADOWSKI S, BALL RG, HOOGSTEEN K: Tryptophan-derived NICir an-tagonists: conformationally constrained heterocyclic biosteres of the ester linkage. J. Med. Chem. (1995) 38:923–933.
- MACLEOD AM, CASCIERI MA, MERCHANT KJ, SADOWSKIS, HARDWICKE S, LEWIS RT, MACINTYRE DE, METZGER JM, FONG TM, SHEPHEARD S, TATTERSALL FD, HAR-GREAVES R, BAKER R: Synthesis and biological evalu-ation of NIQ antagonists derived from L-tryptophan. J. Med. Chem. (1995) 38:934–941.
- Scrip (1994) 24:1984.
References to Patent Literature
- ELI LILLY & COMPANY, W09514017 (1995).
- FUJISAWA PHARMACEUTICAL CO. LTD., EP-655442-A (1995).
- GLAXO GROUP LIMITED, W09508549 (1995).
- MERCK SHARP & DOHME, W09419323 (1994).
- MERCK SHARP & DOHME, W09520575 (1995).
- MERCK SHARP & DOHME, W09521919 (1995).
- MERCK SHARP & DOHME, EP-577394-A (1994).
- MERCK SHARP & DOHME, W09403429 (1994).
- MERCK SHARP & DOHME, W09504042 (1995).
- MERCK SHARP & DOHME, W09407843 (1994).
- MERCK SHARP & DOHME, GB2271774-A (1994).
- MERCK SHARP & DOHME, W09410168 (1994).
- MERCK SHARP & DOHME, GB2282807-A (1995).
- MERCK SHARP & DOHME, W09419320 (1994).
- MERCK SHARP & DOHME, W09407839 (1994).
- MERCK SHARP & DOHME, W09417045 (1994).
- MERCK SHARP & DOHME, W09429309 (1995).
- MERCK SHARP & DOHME, US5434158 (1994).
- PFIZER INCORPORATED, W09408997 (1994).
- RHONE-POULENC RORER SA, W09422822 (1995).